Health News Releases

09:53

Merck Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector

Merck, a leading science and technology company, today announced the appointment of David Weinreich, MD, MBA, as Global Head of R&D and Chief Medical Officer for its Healthcare business sector. Wei

09:47

IFF Tackles Top Challenges in Baking at IBIE 2025

IFF (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.iff.com&esheet=54316321&newsitemid=20250902465856&lan=en-US&anchor=IFF&index=1&md5=e0f385d40a254be09c3e473ae8058dde) (NYSE: IF

August 31, 14:35

BeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL)

BeOne Medicines Ltd. (https://beonemedicines.com/) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from a Phase 1/2 study (BGB-11417-201) o

August 29, 11:30

Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue Sarcoma

Novotech, a globally recognized full-service clinical research organization (CRO), is proud to have partnered with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ Pharma) in achieving a signifi

August 28, 11:20

IFF and Reservas Votorantim Sign Bioprospecting Partnership in Brazil

IFF (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.iff.com%2F&esheet=54313323&newsitemid=20250827881934&lan=en-US&anchor=IFF&index=1&md5=aa3a4d050325a3165d01099ca70062f3) (NYSE

August 26, 13:40

SBC Medical Appoints Dr. Ewen Chee as Lead Doctor for Asia Strategy to Accelerate Global Expansion

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announ

August 26, 10:50

BeOne Medicines Announces IMDELLTRA Royalty Purchase Agreement for up to $950 Million

BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fbeonemedicines.com%2F&esheet=54312218&newsitemid=20250825210828&lan=en-US&anchor=BeOne+Medicines+Ltd&index=1&md5

August 22, 09:35

European Commission Approves Tablet Formulation of BeOne Medicines’ BRUKINSA® for All Approved Indications

BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fbeonemedicines.com%2F&esheet=54311084&newsitemid=20250821182068&lan=en-US&anchor=BeOne+Medicines+Ltd.&index=1&md5

August 13, 10:10

PL Developments Builds a Smarter, Healthier Supply Chain with Kinaxis

Kinaxis® (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.kinaxis.com%2Fen&esheet=54306533&newsitemid=20250812652131&lan=en-US&anchor=Kinaxis%26%23174%3B&index=1&md5=43390a81b573

August 08, 17:10

Polpharma Biologics and Fresenius Kabi Sign Licensing Agreement for Proposed Vedolizumab Biosimilar PB016

Polpharma Biologics S.A. (“Polpharma Biologics”) announces a global (except for Middle East & North Africa) licensing agreement with Fresenius Kabi for the commercialization of PB016, a proposed biosi

August 08, 15:00

BeOne Medicines Announces Second Quarter 2025 Financial Results and Business Updates

BeOne Medicines Ltd. (https://beonemedicines.com/) (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and corporate updates from the second quarter o

August 08, 11:20

HistoSonics Announces $2.25B Acquisition by Consortium of Top-Tier Investors

HistoSonics (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.histosonics.com&esheet=54304409&newsitemid=20250807749442&lan=en-US&anchor=HistoSonics&index=1&md5=f0e9f5c34e97c8b8bfd

August 05, 15:50

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

Concept Medical Inc. (https://www.conceptmedical.com/), a global pioneer in drug-delivery technologies, announced the enrollment of the first patient in the MAGICAL-SV (MAGIcTouch™ Sirolimus-Coated Ba

August 05, 15:00

Nucleus Network Acquires Hammersmith Medicines Research

Nucleus Network, a global leader in early phase clinical research, today announced the acquisition of Hammersmith Medicines Research (HMR), one of the United Kingdom’s most respected early phase clini

August 01, 13:40

BeOne Medicines Receives PRIME Designation from the European Medicines Agency for BGB-16673 in Waldenstrom’s Macroglobulinemia

BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fbeonemedicines.com%2F&esheet=54299902&newsitemid=20250731014937&lan=en-US&anchor=BeOne+Medicines+Ltd.&index=1&md5

July 30, 16:11

Takeda Announces First-Quarter FY2025 Results With Significant Late-Stage Pipeline Progression

Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54297300&newsitemid=20250727920112&lan=en-US&anc

July 30, 15:40

Rigaku Launches XTRAIA XD-3300 Mass Production for Semiconductor Market

Rigaku Corporation, a global solution partner in X-ray metrology systems and a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”), ha

July 30, 15:20

Novotech Awarded Veeva Hero Award at 2025 Veeva R&D and Quality Summit

Novotech, a globally recognized full-service clinical research organization (CRO), is proud to announce that we have received the highly regarded Veeva Hero award presented at the 2025 Veeva R&D and Q

July 29, 11:54

BARRICURE Officially Sponsors SPDU 2025 in Malaysia Collaborating with CHAYA AND LIGHT SDN. BHD. for Local Professional Promotion

BARRICURE, the dermatology-focused medical device brand of MEDIPEAU Inc, Ltd., participated as an official sponsor at the Sarawak Paediatric Dermatology Update 2025 (SPDU 2025), held on July 26, 2025,

July 29, 11:10

BeOne Medicines Receives Positive CHMP Opinion for TEVIMBRA® in Neoadjuvant/Adjuvant NSCLC Treatment

BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fbeonemedicines.com%2F&esheet=54297275&newsitemid=20250728331235&lan=en-US&anchor=BeOne+Medicines+Ltd.&index=1&md5

July 29, 10:55

Biocytogen Upgrades Preclinical Service Platform and Launches Revamped Global Website

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technolo

July 27, 10:33

Endoscopic AI: AI Medical Service Inc. Has Obtained Regulatory Approval from Thailand’s FDA for Its Gastric AI-based Endoscopic Diagnosis Support System

AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, is excited to announce that it has received medical device approval from the

July 25, 13:30

Amazfit Announces Ultra Runner Rod Farvard as New Brand Ambassador

Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), announced ultra runner Rod Farvard as the newest athlete ambassador. Farvard’s approach to endurance racing, a combin

July 25, 11:30

LEO Pharma Announces FDA Approval of ANZUPGO® (delgocitinib) Cream in the U.S.

LEO Pharma, a global leader in medical dermatology, announced today that the U.S. Food and Drug Administration (FDA) has approved ANZUPGO® (delgocitinib) cream (20 mg/g) for the topical treatment of m

July 24, 14:52

Galderma Delivers Record First Half 2025 Net Sales of 2.448 Billion USD and 12.2% Year-on-Year Growth at Constant Currency, Raises Full-Year Top-Line Guidance

Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the first half of 2025. · Record net sales of 2.448 billion USD, representing net

News by Region

News by Industry